Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| PhaseBio Pharmaceuticals Inc | 41 236 | déclaré | 20 mai 2022 | tx 20+288 108−17 774 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 20 mai 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 10 917 | 0.68 USD | |
| 24 févr. 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 87 500 | 0.00 USD | deriv |
| 24 févr. 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 18 750 | 0.00 USD | deriv |
| 19 nov. 2021 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 2 559 | 2.01 USD | |
| 12 juil. 2021 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 4 519 | 1.74 USD | |
| 20 mai 2021 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 5 257 | 2.80 USD | |
| 05 févr. 2021 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 36 000 | 0.00 USD | deriv |
| 20 nov. 2020 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 4 832 | 3.00 USD | |
| 01 oct. 2020 | EXERCISE | PhaseBio Pharmaceuticals Inc | 5 423 | 1.15 USD | |
| 27 févr. 2020 | EXERCISE | PhaseBio Pharmaceuticals Inc | 5 423 | 1.15 USD | |
| 01 oct. 2020 | EXERCISE | PhaseBio Pharmaceuticals Inc | 5 423 | 1.15 USD | deriv |
| 27 févr. 2020 | EXERCISE | PhaseBio Pharmaceuticals Inc | 5 423 | 1.15 USD | deriv |
| 12 févr. 2020 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 55 000 | 0.00 USD | deriv |
| 27 févr. 2019 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 45 000 | 0.00 USD | deriv |
| 22 oct. 2018 | CONVERSION | PhaseBio Pharmaceuticals Inc | 2 306 | — | |
| 22 oct. 2018 | EXERCISE | PhaseBio Pharmaceuticals Inc | 103 | 0.00 USD | deriv |
| 22 oct. 2018 | CONVERSION | PhaseBio Pharmaceuticals Inc | 2 306 | 0.00 USD | deriv |
| 22 oct. 2018 | EXERCISE | PhaseBio Pharmaceuticals Inc | 103 | 0.12 USD | deriv |